Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase.
about
Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study.Feasibility of internet-based health-related quality of life data collection in a large patient cohort.A promising method for identifying cross-cultural differences in patient perspective: the use of Internet-based focus groups for content validation of new patient reported outcome assessments.Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).Reliability of health-related quality-of-life indicators in cancer survivors from a population-based sample, 2005, BRFSS.Trait anxiety as an independent predictor of poor health-related quality of life and post-traumatic stress symptoms in rectal cancer.A second national survey of health-related quality of life questionnaires in head and neck oncologyHow do interventions designed to improve provider-patient communication work? Illustrative applications of a framework for communication.Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges.Fear of cancer recurrence: a systematic literature review of self-report measures.A systematic review of large-scale surveys of cancer survivors conducted in North America, 2000-2011.Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.The Cancer Outcomes Measurement Working Group: rationale overview and a look to the future.The utility of the behavioral risk factor surveillance system (BRFSS) in testing quality of life theory: an evaluation using structural equation modeling.Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.Towards power and sample size calculations for the comparison of two groups of patients with item response theory models.Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need?
P2860
Q33546139-884C8D94-C0E1-455F-91B7-B7C2FDE54F19Q33663119-D96C74E0-2593-4D44-A81C-EE6010372909Q35121205-91F238ED-6445-47B4-8F91-57FC301C0897Q36002272-3809229E-C66A-442F-AD82-D2D421B04072Q37281613-586C4324-5119-4F69-BD3B-DA646C79B5A9Q37373281-442F73AA-5160-478A-A3E8-94D49D8D00AFQ37378910-43A8ECA8-AC09-4231-B1C4-44C7AD9A0073Q37681001-B4C6A8C0-9B83-45E5-945A-26B4F235DA2EQ37780539-1E8B0ED7-024E-47A0-BEF7-E97701F99F6AQ37948703-C48595D4-522D-49D0-A767-EB643AA14F74Q37990474-9B361624-1EDC-4B34-AB50-F7CAFB08EA08Q38198624-9776704F-E0C4-4EE7-890E-1B23EB120F6BQ40302773-5E9489B0-979D-4BC6-86EF-29B068C89257Q43897301-64B2A7F7-7759-43C8-9CE7-AAA73AE899F6Q45754894-8DE7136F-1C33-48B9-B9B9-CFC061F0157BQ47345068-202C1A3D-A6F8-4C44-BF0E-CE4A04D47D9CQ48849283-8764CD4C-1F10-4364-A9C2-3BE534D06696
P2860
Reflections on findings of the Cancer Outcomes Measurement Working Group: moving to the next phase.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Reflections on findings of the ...... oup: moving to the next phase.
@en
type
label
Reflections on findings of the ...... oup: moving to the next phase.
@en
prefLabel
Reflections on findings of the ...... oup: moving to the next phase.
@en
P2093
P356
P1476
Reflections on findings of the ...... oup: moving to the next phase.
@en
P2093
Carolyn C Gotay
Claire F Snyder
Joseph Lipscomb
P304
P356
10.1093/JNCI/DJI337
P407
P577
2005-11-01T00:00:00Z